Cargando…

Effect of different doses of aspirin on the prognosis of Kawasaki disease

BACKGROUND: Kawasaki disease (KD) is the leading cause of acquired heart disease in children, and is steadily increasing in prevalence in East Asia. KD is often complicated by coronary artery damage, including dilatation and/or aneurysms. Aspirin is used with intravenous immunoglobulin (IVIG) to pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinxin, Chen, Huiqiao, Shi, Hongying, Zhang, Xuting, Shao, Yiping, Hang, Biyao, Xu, Zhipeng, Rong, Xing, Chu, Maoping, Qiu, Huixian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291457/ https://www.ncbi.nlm.nih.gov/pubmed/32527316 http://dx.doi.org/10.1186/s12969-020-00432-x

Ejemplares similares

Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study
por: Zhang, Xuting, et al.
Publicado: (2021)

Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease
por: Wang, Jinxin, et al.
Publicado: (2020)

Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease
por: Qiu, Huixian, et al.
Publicado: (2020)

Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study
por: Xia, Yuhan, et al.
Publicado: (2022)

Characteristics of Kawasaki Disease Before and After the COVID-19 Pandemic in a Large Pediatric Heart Disease Center
por: Yu, Huan, et al.
Publicado: (2022)

Association between miRNA‐196a2 rs11614913 T>C polymorphism and Kawasaki disease susceptibility in southern Chinese children
por: Wang, Jinxin, et al.
Publicado: (2019)

The Significance of Symptoms in Predicting Coronary Artery Aneurysms of Kawasaki Disease, Especially in Female Patients
por: Yu, Huan, et al.
Publicado: (2022)

Clinical characteristics and correlation analysis of IVIG resistance in children with kawasaki disease complicated with hip synovitis: case-control study
por: Wang, Jianjie, et al.
Publicado: (2023)

Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study
por: Wang, Zhenquan, et al.
Publicado: (2018)

Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation
por: Jia, Chang, et al.
Publicado: (2019)

Clinical follow-up study of 166 cases of children with hypertension
por: Wang, Zhenquan, et al.
Publicado: (2021)

IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway
por: Jia, Chang, et al.
Publicado: (2021)

Correction: IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway
por: Jia, Chang, et al.
Publicado: (2021)

Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?
por: Lee, Goni, et al.
Publicado: (2013)

Association between the miRNA‐149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population
por: Li, Jiawen, et al.
Publicado: (2019)

The association between the miR-146a rs2910164 C>G polymorphism and Kawasaki disease in a southern Chinese population
por: Zhang, Li, et al.
Publicado: (2018)

Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
por: Ito, Yu, et al.
Publicado: (2020)

SIGIRR-caspase-8 signaling mediates endothelial apoptosis in Kawasaki disease
por: Wen, Zhengwang, et al.
Publicado: (2023)

Gene Polymorphism of Aspirin-Induced Urticaria in Children With Kawasaki Disease
por: Zhang, Hui, et al.
Publicado: (2019)

High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
por: Yoo, Jae Won, et al.
Publicado: (2017)

Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm
por: Sanati, Farima, et al.
Publicado: (2021)

CircRNA-3302 promotes endothelial-to-mesenchymal transition via sponging miR-135b-5p to enhance KIT expression in Kawasaki disease
por: Ni, Chao, et al.
Publicado: (2022)

The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease
por: Wang, Fangyan, et al.
Publicado: (2023)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin
por: Platt, Brooks, et al.
Publicado: (2020)

Duration of High-Dose Aspirin Therapy does not Affect Long-Term Coronary Artery Outcomes in Kawasaki Disease
por: Migally, Karl, et al.
Publicado: (2018)

Exploring the Mechanism of Aspirin in the Treatment of Kawasaki Disease Based on Molecular Docking and Molecular Dynamics
por: Xiong, Li, et al.
Publicado: (2022)

The rs1625579 T>G polymorphism in the miRNA-13 gene confers a risk of early- onset Kawasaki disease in a southern Chinese population
por: Che, Di, et al.
Publicado: (2018)

Aspirin-Induced Delayed Urticaria in Children with Kawasaki Disease: A Retrospective Case-Control Study
por: Lin, Yao, et al.
Publicado: (2021)

A case of rectal ulcers during aspirin therapy in acute Kawasaki disease
por: Han, Yong, et al.
Publicado: (2020)

Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2019)

miR-186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease
por: Wu, Rongzhou, et al.
Publicado: (2018)

Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose “IVIG-SN” Therapy for Pediatric Patients with Kawasaki Disease
por: Yoon, Kyung Lim, et al.
Publicado: (2017)

The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury
por: Gao, Lichao, et al.
Publicado: (2023)

Bone Marrow–Derived MicroRNA‐223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease
por: Chu, Maoping, et al.
Publicado: (2017)

Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)

Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2022)

Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin
por: Dai, Shao-Xing, et al.
Publicado: (2016)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9e7oogddut0tleshbeqhc93f4c